Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 03, 2021	Dec. 29, 2019	Dec. 30, 2018
Cash flows from operating activities:
Net income	$ 117,832	$ 136,940	$ 460,115
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	132,775	131,693	128,879
Share-based compensation	18,930	18,676	17,918
Impairment of long-lived assets	8,037	6,999	4,697
Deferred income tax	10,266	837	(6,568)
Non-cash rental expense (income), net	28,937	28,202	(17,043)
Change in operating lease liabilities	(40,905)	(41,911)	0
Net receipt (recognition) of deferred vendor incentives	2,495	(501)	139
System optimization gains, net	(3,148)	(1,283)	(463)
Gain on sale of investments, net	0	(24,496)	(450,000)
Distributions received from TimWen joint venture	8,376	13,400	13,390
Equity in earnings in joint ventures, net	(6,096)	(8,673)	(8,076)
Long-term debt-related activities, net (see below)	6,723	15,317	18,673
Other, net	(6,438)	(4,838)	5,178
Changes in operating assets and liabilities:
Accounts and notes receivable, net	(16,243)	16,935	13,226
Inventories	(841)	(163)	(434)
Prepaid expenses and other current assets	(8,780)	(1,569)	6,824
Advertising funds restricted assets and liabilities	49,052	(2,720)	13,955
Accounts payable	1,620	1,054	(145)
Accrued expenses and other current liabilities	(18,231)	5,034	23,963
Net cash provided by operating activities	284,361	288,933	224,228
Cash flows from investing activities:
Capital expenditures	(68,969)	(74,453)	(69,857)
Acquisitions	(4,879)	(5,052)	(21,401)
Dispositions	6,091	3,448	3,223
Proceeds from sale of investments	169	24,496	450,000
Notes receivable, net	(662)	(3,370)	959
Payments for investments	0	0	13
Net cash (used in) provided by investing activities	(68,250)	(54,931)	362,911
Cash flows from financing activities:
Proceeds from long-term debt	153,315	850,000	934,837
Repayments of long-term debt	(191,462)	(899,800)	(894,501)
Repayments of finance lease liabilities	(8,383)	(6,835)
Repayments of finance lease liabilities			(5,571)
Deferred financing costs	(2,122)	(14,008)	(17,340)
Repurchases of common stock, including accelerated share repurchase	(62,173)	(217,797)	(269,809)
Dividends	(64,866)	(96,364)	(80,532)
Proceeds from stock option exercises	23,361	28,328	45,228
Payments related to tax withholding for share-based compensation	(5,577)	(8,820)	(11,805)
Contingent consideration payment	0	0	(6,269)
Net cash used in financing activities	(157,907)	(365,296)	(305,762)
Net cash provided by (used in) operations before effect of exchange rate changes on cash	58,204	(131,294)	281,377
Effect of exchange rate changes on cash	1,330	3,489	(7,689)
Net increase (decrease) in cash, cash equivalents and restricted cash	59,534	(127,805)	273,688
Cash, cash equivalents and restricted cash at beginning of period	358,707	486,512	212,824
Cash, cash equivalents and restricted cash at end of period	418,241	358,707	486,512
Long-term debt-related activities, net:
Loss on early extinguishment of debt	0	8,496	11,475
Accretion of long-term debt	1,161	1,272	1,255
Amortization of deferred financing costs	5,562	5,549	5,943
Long-term debt-related activities, net:	6,723	15,317	18,673
Cash paid for:
Interest	136,228	138,270	137,607
Income taxes, net of refunds	16,202	34,798	102,827
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	3,673	6,026	6,460
Finance leases	34,918	50,061
Finance leases			6,569
Reconciliation of cash, cash equivalents and restricted cash at end of period:
Total cash, cash equivalents and restricted cash	$ 418,241	$ 486,512	$ 486,512